The impact of point-of-care testing on cardiovascular risk assessment completion in primary care practice-EPOCH

Authors
Category Primary study
Registry of TrialsANZCTR
Year 2013
INTERVENTION: Intervention study. 10 GP practices using the cobas b101 POC device to test HbA1c and Cholesterol levels in eligible patients in order to complete CVD risk assessment records. A GP or practice nurse at each center will administer the test using standard diagnostic cartridges and a blood sample obtained by pin prick. The number of completed and non‐completed cardiovascular risk profiles of primary health patients achieved using point of care testing over a 12 month period will be compared between the two groups. CONDITION: Cardiovascular Disease Point of care testing PRIMARY OUTCOME: The number of Completed CVD risk assessments obtained from the anonymised GP medical records in both groups using the Predict software programme for collecting cardiovascular risk assessments. SECONDARY OUTCOME: Average time to complete CVD risk assessment obtained from the anonymised GP medical records in both groups using the Predict software programme for collecting cardiovascular risk assessments. Cost analysis of POC device use versus Lab based results for completing CVD risk assessments using cost information provided by PHO's and local laboratories. Incomplete "parked" CVD risk assessments obtained from the anonymised GP medical records in both groups using the Predict software programme for collecting cardiovascular risk assessments. INCLUSION CRITERIA: Male or female are aged at least 35 years and less than 80 years old, and meet New Zealand national age, gender and ethnicity guideline criteria for CVD risk assessment and repeat assessment
Epistemonikos ID: 36421dc87692e78675bdeadd073f18faac9fdff4
First added on: Aug 22, 2024